TCT-28 Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry (OPPOSE)
David Hildick‐Smith(Sussex County Community College), Mark Spence(Mater Private Hospital), Philip MacCarthy(King's College Hospital), Michael Mullen(St Bartholomew's Hospital), Lindsay Morrison(University of Liverpool), C. Duke(Altarum Institute)
Cited by 0
Related Papers
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
|New England Journal of Medicine|2013|918
Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves
|Circulation|2012|580
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
|New England Journal of Medicine|2021|571